SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 53 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,000 | -93.2% | 3,854 | -80.0% | 0.00% | – |
Q1 2019 | $44,000 | -81.7% | 19,249 | -81.6% | 0.00% | – |
Q4 2018 | $241,000 | -76.2% | 104,718 | +53.4% | 0.00% | – |
Q3 2018 | $1,011,000 | +5.5% | 68,280 | +8.1% | 0.00% | – |
Q2 2018 | $958,000 | +132.5% | 63,190 | +187.4% | 0.00% | – |
Q1 2018 | $412,000 | +101.0% | 21,984 | +93.9% | 0.00% | – |
Q4 2017 | $205,000 | +97.1% | 11,338 | +139.8% | 0.00% | – |
Q3 2017 | $104,000 | – | 4,729 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Wealth Management, LLC | 180,552 | $36,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 122,942 | $24,000 | 0.00% |
CITIGROUP INC | 1,739 | $0 | 0.00% |
GOLDMAN SACHS GROUP INC | 52,553 | $11,000 | 0.00% |
MORGAN STANLEY | 101 | $0 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 15,936 | $3,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 20 | $0 | 0.00% |
BlackRock Inc. | 90,036 | $18,000 | 0.00% |
Ballentine Partners, LLC | 16,700 | $3,000 | 0.00% |
Citadel Advisors | 83,839 | $17,000 | 0.00% |